Search the web
Welcome, Guest
[Sign Out, My Account]

Saturday, March 28 2015 1:21am ET - U.S. Markets Closed.
Industry Center
Industry Center > > Elusys Therapeutics, Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
Elusys Therapeutics, Inc. Company Profile
Elusys Therapeutics is recruiting antibodies in its anti-terrorism campaign. The company develops antibody therapies for a variety of targets, including anthrax. Its lead product candidate Anthim is in late-stage clinical trials to treat and prevent inhaled anthrax; Elusys receives federal funding for its research efforts on the drug. The company has partnered with Pfizer on another drug development program targeting Staphylococcus aureus (staph) infections, which have become increasingly prevalent and resistant to treatment. Elusys antibodies have potential applications in the treatment of additional infectious agents.
Headlines for Elusys Therapeutics, Inc.
FDA approves Emergent BioSolutions' inhaled anthrax treatment
- Wed Mar 25
Contact Information
Address: 25 Riverside Dr.
Pine Brook, NJ 07058
Financial Highlights
Fiscal Year End:December
Key People
Chairman: Ronald (Ron) Eastman
President, CEO, and Director: Elizabeth G. Posillico
CFO: Robert Love
Industry Information
Top Competitors
Emergent BioSolutions Inc. (ebs)
Human Genome Sciences, Inc.
NovaBay Pharmaceuticals, Inc. (nby)

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?